Review



anti rtp801  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech anti rtp801
    Anti Rtp801, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 865 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rtp801/product/Proteintech
    Average 96 stars, based on 865 article reviews
    anti rtp801 - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    93
    Novus Biologicals rtp801
    Sustained upregulation of <t>RTP801</t> in dopaminergic neurons depends on microglial activation with RBD. (A) Colocalization of TH with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (left, Scale bar = 200 μm). Colocalization of Iba1 with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (right, Scale bar = 50 μm). (B) Schematic of the microglial depletion with PLX5622 experiment. (C) Representative images demonstrating microglial (Iba1 + cells) depletion in the SNc following PLX5622 treatment, in comparison to vehicle mice (Scale bar = 200 μm). (D-E) Behavior analysis of the rotarod test and grip strength test for each group with or without PLX5622 treatment (n = 6). (F) ThS staining in the SNc for each group (Scale bar = 5 μm). (G) Western blot analysis of RTP801 and TH for each group (n = 4). (H) Colocalization of Iba1 and TH with His-tag RBD in the SNc at day 1, 3 and 7 after treated with RBD or vehicle (Scale bar = 5 μm). (I) Western blot analysis of RTP801 of neurons treated with RBD or MCM (n = 4). (J) Western blot analysis of RTP801 of SH-SY5Y-αSyn A53T cells treated with RBD or MCM and inhibitors (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.
    Rtp801, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rtp801/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    rtp801 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals anti rtp801
    Sustained upregulation of <t>RTP801</t> in dopaminergic neurons depends on microglial activation with RBD. (A) Colocalization of TH with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (left, Scale bar = 200 μm). Colocalization of Iba1 with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (right, Scale bar = 50 μm). (B) Schematic of the microglial depletion with PLX5622 experiment. (C) Representative images demonstrating microglial (Iba1 + cells) depletion in the SNc following PLX5622 treatment, in comparison to vehicle mice (Scale bar = 200 μm). (D-E) Behavior analysis of the rotarod test and grip strength test for each group with or without PLX5622 treatment (n = 6). (F) ThS staining in the SNc for each group (Scale bar = 5 μm). (G) Western blot analysis of RTP801 and TH for each group (n = 4). (H) Colocalization of Iba1 and TH with His-tag RBD in the SNc at day 1, 3 and 7 after treated with RBD or vehicle (Scale bar = 5 μm). (I) Western blot analysis of RTP801 of neurons treated with RBD or MCM (n = 4). (J) Western blot analysis of RTP801 of SH-SY5Y-αSyn A53T cells treated with RBD or MCM and inhibitors (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.
    Anti Rtp801, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rtp801/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    anti rtp801 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    96
    Proteintech anti rtp801
    Sustained upregulation of <t>RTP801</t> in dopaminergic neurons depends on microglial activation with RBD. (A) Colocalization of TH with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (left, Scale bar = 200 μm). Colocalization of Iba1 with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (right, Scale bar = 50 μm). (B) Schematic of the microglial depletion with PLX5622 experiment. (C) Representative images demonstrating microglial (Iba1 + cells) depletion in the SNc following PLX5622 treatment, in comparison to vehicle mice (Scale bar = 200 μm). (D-E) Behavior analysis of the rotarod test and grip strength test for each group with or without PLX5622 treatment (n = 6). (F) ThS staining in the SNc for each group (Scale bar = 5 μm). (G) Western blot analysis of RTP801 and TH for each group (n = 4). (H) Colocalization of Iba1 and TH with His-tag RBD in the SNc at day 1, 3 and 7 after treated with RBD or vehicle (Scale bar = 5 μm). (I) Western blot analysis of RTP801 of neurons treated with RBD or MCM (n = 4). (J) Western blot analysis of RTP801 of SH-SY5Y-αSyn A53T cells treated with RBD or MCM and inhibitors (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.
    Anti Rtp801, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rtp801/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti rtp801 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    94
    Proteintech rtp801 antibody
    <t>RTP801</t> is present in EVs and its overexpression increases EVs release. For EVs characterization, EVs were isolated from the culture media of cortical neurons at DIV13 following a sequential ultracentrifugation protocol. (a) Size distribution of nanoparticles by NanoSight particle tracking analysis (NTA). (b) Transmission electron micrographs of the vesicles show particles with the characteristic morphology and size of EVs. (c) WB analysis of total cell lysates, large EVs (P10K or lEVs) and small EVs (P100K or sEVs). Membranes were probed against common EVs markers (Alix, TSG‐101 and Flotillin‐1), EVs negative marker (Calnexin), and RTP801. Actin is used as a loading control for the lysates. (d) Cultured neurons were transfected at DIV12 with an eGFP plasmid (in green). EVs were isolated from sister neuronal cultures and labeled with the fluorogenic cell membrane probe MemGlow‐560 (in red). EVs particles were administered to eGFP‐cultured neurons with a ratio of 400 EVs:cell. MemGlow‐560 specifically binds to EVs, as no fluorescent signal was detected in 1X PBS samples. Orthogonal views show EVs internalization into neurons. Scale bar of 5 µm. (e) Cortical primary neurons (DIV11) were transduced with lentiviral particles containing eGFP empty vector (as control) or eGFP‐RTP801 constructs. 48 h after, EVs were isolated and total protein content was analysed by WB. Membranes were probed against RTP801 and eGFP, TSG‐101, and flotillin‐1 as EVs markers and actin as a loading control for the lysates. Representative immunoblots are shown. (f) Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by unpaired T ‐test with Welch's correction in the cell lysate and in the EVs fraction (* P < 0.05 vs. control EVs).
    Rtp801 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rtp801 antibody/product/Proteintech
    Average 94 stars, based on 1 article reviews
    rtp801 antibody - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    90
    Proteintech rabbit polyclonal anti‐rtp801 antibody
    <t>RTP801</t> is present in EVs and its overexpression increases EVs release. For EVs characterization, EVs were isolated from the culture media of cortical neurons at DIV13 following a sequential ultracentrifugation protocol. (a) Size distribution of nanoparticles by NanoSight particle tracking analysis (NTA). (b) Transmission electron micrographs of the vesicles show particles with the characteristic morphology and size of EVs. (c) WB analysis of total cell lysates, large EVs (P10K or lEVs) and small EVs (P100K or sEVs). Membranes were probed against common EVs markers (Alix, TSG‐101 and Flotillin‐1), EVs negative marker (Calnexin), and RTP801. Actin is used as a loading control for the lysates. (d) Cultured neurons were transfected at DIV12 with an eGFP plasmid (in green). EVs were isolated from sister neuronal cultures and labeled with the fluorogenic cell membrane probe MemGlow‐560 (in red). EVs particles were administered to eGFP‐cultured neurons with a ratio of 400 EVs:cell. MemGlow‐560 specifically binds to EVs, as no fluorescent signal was detected in 1X PBS samples. Orthogonal views show EVs internalization into neurons. Scale bar of 5 µm. (e) Cortical primary neurons (DIV11) were transduced with lentiviral particles containing eGFP empty vector (as control) or eGFP‐RTP801 constructs. 48 h after, EVs were isolated and total protein content was analysed by WB. Membranes were probed against RTP801 and eGFP, TSG‐101, and flotillin‐1 as EVs markers and actin as a loading control for the lysates. Representative immunoblots are shown. (f) Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by unpaired T ‐test with Welch's correction in the cell lysate and in the EVs fraction (* P < 0.05 vs. control EVs).
    Rabbit Polyclonal Anti‐Rtp801 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti‐rtp801 antibody/product/Proteintech
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti‐rtp801 antibody - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    94
    Proteintech anti rtp801 antibody
    <t>RTP801</t> is present in EVs and its overexpression increases EVs release. For EVs characterization, EVs were isolated from the culture media of cortical neurons at DIV13 following a sequential ultracentrifugation protocol. (a) Size distribution of nanoparticles by NanoSight particle tracking analysis (NTA). (b) Transmission electron micrographs of the vesicles show particles with the characteristic morphology and size of EVs. (c) WB analysis of total cell lysates, large EVs (P10K or lEVs) and small EVs (P100K or sEVs). Membranes were probed against common EVs markers (Alix, TSG‐101 and Flotillin‐1), EVs negative marker (Calnexin), and RTP801. Actin is used as a loading control for the lysates. (d) Cultured neurons were transfected at DIV12 with an eGFP plasmid (in green). EVs were isolated from sister neuronal cultures and labeled with the fluorogenic cell membrane probe MemGlow‐560 (in red). EVs particles were administered to eGFP‐cultured neurons with a ratio of 400 EVs:cell. MemGlow‐560 specifically binds to EVs, as no fluorescent signal was detected in 1X PBS samples. Orthogonal views show EVs internalization into neurons. Scale bar of 5 µm. (e) Cortical primary neurons (DIV11) were transduced with lentiviral particles containing eGFP empty vector (as control) or eGFP‐RTP801 constructs. 48 h after, EVs were isolated and total protein content was analysed by WB. Membranes were probed against RTP801 and eGFP, TSG‐101, and flotillin‐1 as EVs markers and actin as a loading control for the lysates. Representative immunoblots are shown. (f) Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by unpaired T ‐test with Welch's correction in the cell lysate and in the EVs fraction (* P < 0.05 vs. control EVs).
    Anti Rtp801 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rtp801 antibody/product/Proteintech
    Average 94 stars, based on 1 article reviews
    anti rtp801 antibody - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    Proteintech rabbit polyclonal anti rtp801
    <t>RTP801</t> is present in EVs and its overexpression increases EVs release. For EVs characterization, EVs were isolated from the culture media of cortical neurons at DIV13 following a sequential ultracentrifugation protocol. (a) Size distribution of nanoparticles by NanoSight particle tracking analysis (NTA). (b) Transmission electron micrographs of the vesicles show particles with the characteristic morphology and size of EVs. (c) WB analysis of total cell lysates, large EVs (P10K or lEVs) and small EVs (P100K or sEVs). Membranes were probed against common EVs markers (Alix, TSG‐101 and Flotillin‐1), EVs negative marker (Calnexin), and RTP801. Actin is used as a loading control for the lysates. (d) Cultured neurons were transfected at DIV12 with an eGFP plasmid (in green). EVs were isolated from sister neuronal cultures and labeled with the fluorogenic cell membrane probe MemGlow‐560 (in red). EVs particles were administered to eGFP‐cultured neurons with a ratio of 400 EVs:cell. MemGlow‐560 specifically binds to EVs, as no fluorescent signal was detected in 1X PBS samples. Orthogonal views show EVs internalization into neurons. Scale bar of 5 µm. (e) Cortical primary neurons (DIV11) were transduced with lentiviral particles containing eGFP empty vector (as control) or eGFP‐RTP801 constructs. 48 h after, EVs were isolated and total protein content was analysed by WB. Membranes were probed against RTP801 and eGFP, TSG‐101, and flotillin‐1 as EVs markers and actin as a loading control for the lysates. Representative immunoblots are shown. (f) Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by unpaired T ‐test with Welch's correction in the cell lysate and in the EVs fraction (* P < 0.05 vs. control EVs).
    Rabbit Polyclonal Anti Rtp801, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti rtp801/product/Proteintech
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti rtp801 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    Image Search Results


    Sustained upregulation of RTP801 in dopaminergic neurons depends on microglial activation with RBD. (A) Colocalization of TH with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (left, Scale bar = 200 μm). Colocalization of Iba1 with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (right, Scale bar = 50 μm). (B) Schematic of the microglial depletion with PLX5622 experiment. (C) Representative images demonstrating microglial (Iba1 + cells) depletion in the SNc following PLX5622 treatment, in comparison to vehicle mice (Scale bar = 200 μm). (D-E) Behavior analysis of the rotarod test and grip strength test for each group with or without PLX5622 treatment (n = 6). (F) ThS staining in the SNc for each group (Scale bar = 5 μm). (G) Western blot analysis of RTP801 and TH for each group (n = 4). (H) Colocalization of Iba1 and TH with His-tag RBD in the SNc at day 1, 3 and 7 after treated with RBD or vehicle (Scale bar = 5 μm). (I) Western blot analysis of RTP801 of neurons treated with RBD or MCM (n = 4). (J) Western blot analysis of RTP801 of SH-SY5Y-αSyn A53T cells treated with RBD or MCM and inhibitors (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.

    Journal: Journal of Advanced Research

    Article Title: Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation

    doi: 10.1016/j.jare.2025.07.060

    Figure Lengend Snippet: Sustained upregulation of RTP801 in dopaminergic neurons depends on microglial activation with RBD. (A) Colocalization of TH with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (left, Scale bar = 200 μm). Colocalization of Iba1 with RTP801 in the SNc at day 1, 3 and 7 after treated with RBD (right, Scale bar = 50 μm). (B) Schematic of the microglial depletion with PLX5622 experiment. (C) Representative images demonstrating microglial (Iba1 + cells) depletion in the SNc following PLX5622 treatment, in comparison to vehicle mice (Scale bar = 200 μm). (D-E) Behavior analysis of the rotarod test and grip strength test for each group with or without PLX5622 treatment (n = 6). (F) ThS staining in the SNc for each group (Scale bar = 5 μm). (G) Western blot analysis of RTP801 and TH for each group (n = 4). (H) Colocalization of Iba1 and TH with His-tag RBD in the SNc at day 1, 3 and 7 after treated with RBD or vehicle (Scale bar = 5 μm). (I) Western blot analysis of RTP801 of neurons treated with RBD or MCM (n = 4). (J) Western blot analysis of RTP801 of SH-SY5Y-αSyn A53T cells treated with RBD or MCM and inhibitors (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.

    Article Snippet: The membranes were then blocked using 5 % BSA in TBST and incubated overnight at 4 °C with the following primary antibodies: TH (1:500, Santa Cruz, sc-25269), 5G4 (1:1000, Sigma-Aldrich, MABN389), αSyn (1:1000, Abcam, ab138501), cGAS (1:500, Proteintech, 26416–1-AP), STING (1:2000, Proteintech, 19851–1-AP), TBK1 (1:1000, Proteintech, 28397–1-AP;), p-TBK1 (1:1000, Cell Signaling Technology, 5483S), IRF3 (1:5000, Proteintech, 66670–1-Ig), p-IRF3 (1:1000, Cell Signaling Technology, 29047S), RTP801 (1:1000, NOVUS, NBP1-77321) and β-actin (1:10000, ABclonal, AC026), followed by secondary antibodies (1:5000, KPL, Maryland, USA) at room temperature for 2 h. Protein bands were visualized using an Image Quant LAS 4000 mini (GE, Boston, USA), and their intensities were quantified using ImageJ software (Maryland, USA).

    Techniques: Activation Assay, Comparison, Staining, Western Blot

    RBD accelerates PD progression with significantly upregulation of RTP801. (A) Volcano plot of differentially expression genes of RBD treatment compared with vehicle in CSGS 1w model mice. Significantly upregulated genes are colored in orange, significantly downregulated genes are colored in blue, and the rest genes are colored in gray. (B) Gene Ontology enrichment was based on differentially expression genes that have a p value smaller than 0.05, n = 3. (C) Heatmap of selected genes of CSGS 1w model mice treated with RBD or vehicle. (D-E) Relative mRNA levels of the type I interferon (D) and stress-responsive genes (E) in SNc (n = 4). (F) Western blot analysis of RTP801 across groups (n = 4). (G) Colocalization of RTP801 with TH in SNc, scale bar = 200 μm. (H) Pearson’s correlation analysis between RTP801 density and TH + cells number (all values were normalized relative to CSGS 1w + Vehicle group), n = 4 per group. (I) Heatmap of RTP801 and TH colocalization in SNc. Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

    Journal: Journal of Advanced Research

    Article Title: Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation

    doi: 10.1016/j.jare.2025.07.060

    Figure Lengend Snippet: RBD accelerates PD progression with significantly upregulation of RTP801. (A) Volcano plot of differentially expression genes of RBD treatment compared with vehicle in CSGS 1w model mice. Significantly upregulated genes are colored in orange, significantly downregulated genes are colored in blue, and the rest genes are colored in gray. (B) Gene Ontology enrichment was based on differentially expression genes that have a p value smaller than 0.05, n = 3. (C) Heatmap of selected genes of CSGS 1w model mice treated with RBD or vehicle. (D-E) Relative mRNA levels of the type I interferon (D) and stress-responsive genes (E) in SNc (n = 4). (F) Western blot analysis of RTP801 across groups (n = 4). (G) Colocalization of RTP801 with TH in SNc, scale bar = 200 μm. (H) Pearson’s correlation analysis between RTP801 density and TH + cells number (all values were normalized relative to CSGS 1w + Vehicle group), n = 4 per group. (I) Heatmap of RTP801 and TH colocalization in SNc. Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: The membranes were then blocked using 5 % BSA in TBST and incubated overnight at 4 °C with the following primary antibodies: TH (1:500, Santa Cruz, sc-25269), 5G4 (1:1000, Sigma-Aldrich, MABN389), αSyn (1:1000, Abcam, ab138501), cGAS (1:500, Proteintech, 26416–1-AP), STING (1:2000, Proteintech, 19851–1-AP), TBK1 (1:1000, Proteintech, 28397–1-AP;), p-TBK1 (1:1000, Cell Signaling Technology, 5483S), IRF3 (1:5000, Proteintech, 66670–1-Ig), p-IRF3 (1:1000, Cell Signaling Technology, 29047S), RTP801 (1:1000, NOVUS, NBP1-77321) and β-actin (1:10000, ABclonal, AC026), followed by secondary antibodies (1:5000, KPL, Maryland, USA) at room temperature for 2 h. Protein bands were visualized using an Image Quant LAS 4000 mini (GE, Boston, USA), and their intensities were quantified using ImageJ software (Maryland, USA).

    Techniques: Expressing, Western Blot

    RTP801 is critical for PD deterioration induced by RBD. (A) Schematic of the αSyn A53T + ; RTP801 −/− mice experiment. (B) Assessment of olfactory dysfunction was conducted using the BFPT and the visible BFPT. (C) A modified open field test with nuts or paprika quantified olfactory acuity. (D-F) Motor coordination and balance were evaluated using the rotarod (D) , pole (E) , and beam walking (F) tests. ( G ) Forelimb grip strength was gauged through the grip strength test. ( H ) The open field test appraised anxiety-related behaviors, tracking total distance traveled, center zone activity. (I-J) Recognition memory was assessed using Y maze test and NORT. Alternation index (% of total triplet arm entries) was quantified in (I) . New object index was quantified in ( J ) (n = 6). (K) Representative images of TH immunostaining in the SNc and striatum and quantitative assessment (all values were normalized relative to αSyn A53T group), scale bar = 500 μm, n = 4. (L) Western blot analysis of TH expression in SNc and striatum and quantitative analysis (n = 4). (M) Colocalization of RTP801 with TH, scale bar = 200 μm. (N) ThS staining quantifies aggregates in the SNc, including ThS signal density, and the proportion of cells inclusive ThS + puncta (n = 4), scale bar = 5 μm. (O) Western blot detection of αSyn aggregation using the 5G4 antibody, with quantitative analysis confirming significant changes (n = 4). ( P ) Analysis of αSyn partitioning in soluble and insoluble brain fractions by western blot, with quantitative data indicating significant alterations (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.

    Journal: Journal of Advanced Research

    Article Title: Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation

    doi: 10.1016/j.jare.2025.07.060

    Figure Lengend Snippet: RTP801 is critical for PD deterioration induced by RBD. (A) Schematic of the αSyn A53T + ; RTP801 −/− mice experiment. (B) Assessment of olfactory dysfunction was conducted using the BFPT and the visible BFPT. (C) A modified open field test with nuts or paprika quantified olfactory acuity. (D-F) Motor coordination and balance were evaluated using the rotarod (D) , pole (E) , and beam walking (F) tests. ( G ) Forelimb grip strength was gauged through the grip strength test. ( H ) The open field test appraised anxiety-related behaviors, tracking total distance traveled, center zone activity. (I-J) Recognition memory was assessed using Y maze test and NORT. Alternation index (% of total triplet arm entries) was quantified in (I) . New object index was quantified in ( J ) (n = 6). (K) Representative images of TH immunostaining in the SNc and striatum and quantitative assessment (all values were normalized relative to αSyn A53T group), scale bar = 500 μm, n = 4. (L) Western blot analysis of TH expression in SNc and striatum and quantitative analysis (n = 4). (M) Colocalization of RTP801 with TH, scale bar = 200 μm. (N) ThS staining quantifies aggregates in the SNc, including ThS signal density, and the proportion of cells inclusive ThS + puncta (n = 4), scale bar = 5 μm. (O) Western blot detection of αSyn aggregation using the 5G4 antibody, with quantitative analysis confirming significant changes (n = 4). ( P ) Analysis of αSyn partitioning in soluble and insoluble brain fractions by western blot, with quantitative data indicating significant alterations (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.

    Article Snippet: The membranes were then blocked using 5 % BSA in TBST and incubated overnight at 4 °C with the following primary antibodies: TH (1:500, Santa Cruz, sc-25269), 5G4 (1:1000, Sigma-Aldrich, MABN389), αSyn (1:1000, Abcam, ab138501), cGAS (1:500, Proteintech, 26416–1-AP), STING (1:2000, Proteintech, 19851–1-AP), TBK1 (1:1000, Proteintech, 28397–1-AP;), p-TBK1 (1:1000, Cell Signaling Technology, 5483S), IRF3 (1:5000, Proteintech, 66670–1-Ig), p-IRF3 (1:1000, Cell Signaling Technology, 29047S), RTP801 (1:1000, NOVUS, NBP1-77321) and β-actin (1:10000, ABclonal, AC026), followed by secondary antibodies (1:5000, KPL, Maryland, USA) at room temperature for 2 h. Protein bands were visualized using an Image Quant LAS 4000 mini (GE, Boston, USA), and their intensities were quantified using ImageJ software (Maryland, USA).

    Techniques: Olfactory, Modification, Activity Assay, Immunostaining, Western Blot, Expressing, Staining

    RTP801 and the mtDNA-cGAS-STING-IFNβ pathway drive RBD-induced neurodegeneration. (A) Heatmap of mitochondrial genes in SNc of CSGS 1w model mice treated with RBD or vehicle. (B) Relative mRNA levels of mitochondrial function genes in SNc (n = 4). (C) Ultrastructure of the mitochondria in SNc. Scale bar = 1 µm. Representative TEM photomicrographs intact, swollen, damaged and degenerated mitochondria and the proportion of mitochondria with different forms. Scale bar = 200 nm. The red arrows represent the damaged mitochondria. (D) Western blot analysis of p-DRP1 S616 or 637/DRP1, MFN1, and MFN2 for each group (n = 4). (E) Quantification of cytosolic mtDNA via qPCR (n = 4). (F) Representative immunofluorescence of mtDNA release in SNc using anti-DNA (red) and anti-TOM20 (green) antibodies, and white arrows indicate mtDNA release events (Scale bar = 5 μm, n = 40 cells from 4 mice). (G) Western blot analysis of cGAS, STING, p-TBK1/TBK1, and p-IRF3/IRF3 for each group (n = 4). (H) Relative mRNA level of IFN-β in SNc (n = 4). (I) Serum IFN-β levels were measured (n = 4). (J) Western blot analysis of proteins expression in αSyn A53T + ; RTP801 −/− mice and quantitative analysis (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

    Journal: Journal of Advanced Research

    Article Title: Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation

    doi: 10.1016/j.jare.2025.07.060

    Figure Lengend Snippet: RTP801 and the mtDNA-cGAS-STING-IFNβ pathway drive RBD-induced neurodegeneration. (A) Heatmap of mitochondrial genes in SNc of CSGS 1w model mice treated with RBD or vehicle. (B) Relative mRNA levels of mitochondrial function genes in SNc (n = 4). (C) Ultrastructure of the mitochondria in SNc. Scale bar = 1 µm. Representative TEM photomicrographs intact, swollen, damaged and degenerated mitochondria and the proportion of mitochondria with different forms. Scale bar = 200 nm. The red arrows represent the damaged mitochondria. (D) Western blot analysis of p-DRP1 S616 or 637/DRP1, MFN1, and MFN2 for each group (n = 4). (E) Quantification of cytosolic mtDNA via qPCR (n = 4). (F) Representative immunofluorescence of mtDNA release in SNc using anti-DNA (red) and anti-TOM20 (green) antibodies, and white arrows indicate mtDNA release events (Scale bar = 5 μm, n = 40 cells from 4 mice). (G) Western blot analysis of cGAS, STING, p-TBK1/TBK1, and p-IRF3/IRF3 for each group (n = 4). (H) Relative mRNA level of IFN-β in SNc (n = 4). (I) Serum IFN-β levels were measured (n = 4). (J) Western blot analysis of proteins expression in αSyn A53T + ; RTP801 −/− mice and quantitative analysis (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: The membranes were then blocked using 5 % BSA in TBST and incubated overnight at 4 °C with the following primary antibodies: TH (1:500, Santa Cruz, sc-25269), 5G4 (1:1000, Sigma-Aldrich, MABN389), αSyn (1:1000, Abcam, ab138501), cGAS (1:500, Proteintech, 26416–1-AP), STING (1:2000, Proteintech, 19851–1-AP), TBK1 (1:1000, Proteintech, 28397–1-AP;), p-TBK1 (1:1000, Cell Signaling Technology, 5483S), IRF3 (1:5000, Proteintech, 66670–1-Ig), p-IRF3 (1:1000, Cell Signaling Technology, 29047S), RTP801 (1:1000, NOVUS, NBP1-77321) and β-actin (1:10000, ABclonal, AC026), followed by secondary antibodies (1:5000, KPL, Maryland, USA) at room temperature for 2 h. Protein bands were visualized using an Image Quant LAS 4000 mini (GE, Boston, USA), and their intensities were quantified using ImageJ software (Maryland, USA).

    Techniques: Western Blot, Immunofluorescence, Expressing

    Spike RBD accelerates and sustains PD progression through microglia-neuron crosstalk-mediated RTP801 upregulation. Spike RBD exposure in CSGS 1w mice accelerates the progression of PD, leading to the deterioration of motor and non-motor functions, weakened neuronal connectivity, and increased dyskinesia. Mechanistically, RBD initially activates microglia (days 1–3 post-injection), which then secrete cytokines IL-6 and IL-8, leading to an upregulation of neuronal RTP801 by day 7. This process, coupled with RBD-induced mitochondrial dysfunction and mtDNA release, activates the cGAS-STING pathway in both neurons and microglia. The resulting aberrant increase in RTP801 establishes a detrimental feed-forward loop that sustains neurodegeneration.

    Journal: Journal of Advanced Research

    Article Title: Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation

    doi: 10.1016/j.jare.2025.07.060

    Figure Lengend Snippet: Spike RBD accelerates and sustains PD progression through microglia-neuron crosstalk-mediated RTP801 upregulation. Spike RBD exposure in CSGS 1w mice accelerates the progression of PD, leading to the deterioration of motor and non-motor functions, weakened neuronal connectivity, and increased dyskinesia. Mechanistically, RBD initially activates microglia (days 1–3 post-injection), which then secrete cytokines IL-6 and IL-8, leading to an upregulation of neuronal RTP801 by day 7. This process, coupled with RBD-induced mitochondrial dysfunction and mtDNA release, activates the cGAS-STING pathway in both neurons and microglia. The resulting aberrant increase in RTP801 establishes a detrimental feed-forward loop that sustains neurodegeneration.

    Article Snippet: The membranes were then blocked using 5 % BSA in TBST and incubated overnight at 4 °C with the following primary antibodies: TH (1:500, Santa Cruz, sc-25269), 5G4 (1:1000, Sigma-Aldrich, MABN389), αSyn (1:1000, Abcam, ab138501), cGAS (1:500, Proteintech, 26416–1-AP), STING (1:2000, Proteintech, 19851–1-AP), TBK1 (1:1000, Proteintech, 28397–1-AP;), p-TBK1 (1:1000, Cell Signaling Technology, 5483S), IRF3 (1:5000, Proteintech, 66670–1-Ig), p-IRF3 (1:1000, Cell Signaling Technology, 29047S), RTP801 (1:1000, NOVUS, NBP1-77321) and β-actin (1:10000, ABclonal, AC026), followed by secondary antibodies (1:5000, KPL, Maryland, USA) at room temperature for 2 h. Protein bands were visualized using an Image Quant LAS 4000 mini (GE, Boston, USA), and their intensities were quantified using ImageJ software (Maryland, USA).

    Techniques: Injection

    RTP801 is present in EVs and its overexpression increases EVs release. For EVs characterization, EVs were isolated from the culture media of cortical neurons at DIV13 following a sequential ultracentrifugation protocol. (a) Size distribution of nanoparticles by NanoSight particle tracking analysis (NTA). (b) Transmission electron micrographs of the vesicles show particles with the characteristic morphology and size of EVs. (c) WB analysis of total cell lysates, large EVs (P10K or lEVs) and small EVs (P100K or sEVs). Membranes were probed against common EVs markers (Alix, TSG‐101 and Flotillin‐1), EVs negative marker (Calnexin), and RTP801. Actin is used as a loading control for the lysates. (d) Cultured neurons were transfected at DIV12 with an eGFP plasmid (in green). EVs were isolated from sister neuronal cultures and labeled with the fluorogenic cell membrane probe MemGlow‐560 (in red). EVs particles were administered to eGFP‐cultured neurons with a ratio of 400 EVs:cell. MemGlow‐560 specifically binds to EVs, as no fluorescent signal was detected in 1X PBS samples. Orthogonal views show EVs internalization into neurons. Scale bar of 5 µm. (e) Cortical primary neurons (DIV11) were transduced with lentiviral particles containing eGFP empty vector (as control) or eGFP‐RTP801 constructs. 48 h after, EVs were isolated and total protein content was analysed by WB. Membranes were probed against RTP801 and eGFP, TSG‐101, and flotillin‐1 as EVs markers and actin as a loading control for the lysates. Representative immunoblots are shown. (f) Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by unpaired T ‐test with Welch's correction in the cell lysate and in the EVs fraction (* P < 0.05 vs. control EVs).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: RTP801 is present in EVs and its overexpression increases EVs release. For EVs characterization, EVs were isolated from the culture media of cortical neurons at DIV13 following a sequential ultracentrifugation protocol. (a) Size distribution of nanoparticles by NanoSight particle tracking analysis (NTA). (b) Transmission electron micrographs of the vesicles show particles with the characteristic morphology and size of EVs. (c) WB analysis of total cell lysates, large EVs (P10K or lEVs) and small EVs (P100K or sEVs). Membranes were probed against common EVs markers (Alix, TSG‐101 and Flotillin‐1), EVs negative marker (Calnexin), and RTP801. Actin is used as a loading control for the lysates. (d) Cultured neurons were transfected at DIV12 with an eGFP plasmid (in green). EVs were isolated from sister neuronal cultures and labeled with the fluorogenic cell membrane probe MemGlow‐560 (in red). EVs particles were administered to eGFP‐cultured neurons with a ratio of 400 EVs:cell. MemGlow‐560 specifically binds to EVs, as no fluorescent signal was detected in 1X PBS samples. Orthogonal views show EVs internalization into neurons. Scale bar of 5 µm. (e) Cortical primary neurons (DIV11) were transduced with lentiviral particles containing eGFP empty vector (as control) or eGFP‐RTP801 constructs. 48 h after, EVs were isolated and total protein content was analysed by WB. Membranes were probed against RTP801 and eGFP, TSG‐101, and flotillin‐1 as EVs markers and actin as a loading control for the lysates. Representative immunoblots are shown. (f) Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by unpaired T ‐test with Welch's correction in the cell lysate and in the EVs fraction (* P < 0.05 vs. control EVs).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Over Expression, Isolation, Transmission Assay, Marker, Control, Cell Culture, Transfection, Plasmid Preparation, Labeling, Membrane, Transduction, Construct, Western Blot

    Modulation of RTP801 expression alters protein cargo of neuronal‐derived EVs in vitro. (a) Heatmap showing the differentially expressed proteins in GFP and RTP801‐derived EVs. Significantly overexpressed proteins in the RTP801 group in comparison to the GFP group are depicted in red, whereas proteins that are underrepresented in the RTP801 group are shown in blue. In the right annotation the log2 fold change (FC) is displayed as a bar plot for each of the proteins. (b) The volcano plot shows the whole set of proteins detected in the comparison between GFP and RTP801 experimental groups. The most overexpressed proteins being significant (‐log10 p‐value > = 1.2 and log2 fold change < −2.5) are plotted in red and the most downregulated proteins (‐log10 p‐value > = 1.2 and log2 fold change > 2.5) in blue. (c) Heatmap showing the differentially expressed proteins in shCT and shRTP801‐derived EVs. Significantly overexpressed proteins in the shRTP801 group in comparison to the shCT group are depicted in red, whereas proteins that are underrepresented in the shRTP801 group are shown in blue. In the right annotation, the log2 fold change (FC) is displayed as a barplot for each of the proteins. (d) The volcano plot shows the whole set of proteins detected in the comparison between shCT and shRTP801 experimental groups. The most overexpressed proteins being significant (‐log10 p‐value > = 1.2 and log2 fold change < −2.5) are plotted in red and the most downregulated proteins (‐log10 p‐value > = 1.2 and log2 fold change > 2.5) in blue. In both cases, these proteins are also tagged with the gene symbol. In both cases these proteins are also tagged with the gene symbol. Note that the heatmaps (a) and (c) only show the differentially expressed proteins between groups, while the whole set of proteins is used for the representation in volcano plots (b) and (d).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: Modulation of RTP801 expression alters protein cargo of neuronal‐derived EVs in vitro. (a) Heatmap showing the differentially expressed proteins in GFP and RTP801‐derived EVs. Significantly overexpressed proteins in the RTP801 group in comparison to the GFP group are depicted in red, whereas proteins that are underrepresented in the RTP801 group are shown in blue. In the right annotation the log2 fold change (FC) is displayed as a bar plot for each of the proteins. (b) The volcano plot shows the whole set of proteins detected in the comparison between GFP and RTP801 experimental groups. The most overexpressed proteins being significant (‐log10 p‐value > = 1.2 and log2 fold change < −2.5) are plotted in red and the most downregulated proteins (‐log10 p‐value > = 1.2 and log2 fold change > 2.5) in blue. (c) Heatmap showing the differentially expressed proteins in shCT and shRTP801‐derived EVs. Significantly overexpressed proteins in the shRTP801 group in comparison to the shCT group are depicted in red, whereas proteins that are underrepresented in the shRTP801 group are shown in blue. In the right annotation, the log2 fold change (FC) is displayed as a barplot for each of the proteins. (d) The volcano plot shows the whole set of proteins detected in the comparison between shCT and shRTP801 experimental groups. The most overexpressed proteins being significant (‐log10 p‐value > = 1.2 and log2 fold change < −2.5) are plotted in red and the most downregulated proteins (‐log10 p‐value > = 1.2 and log2 fold change > 2.5) in blue. In both cases, these proteins are also tagged with the gene symbol. In both cases these proteins are also tagged with the gene symbol. Note that the heatmaps (a) and (c) only show the differentially expressed proteins between groups, while the whole set of proteins is used for the representation in volcano plots (b) and (d).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Expressing, Derivative Assay, In Vitro, Comparison

    Significantly altered proteins involved in apoptosis found in EVs derived from  RTP801‐overexpressing  neurons compared to the control. Pro‐apoptotic proteins are shown in red, anti‐apoptotic proteins in green, and proteins with a dual role as pro‐ and anti‐apoptotic in orange. Up‐arrows indicate that the protein is upregulated and down‐arrows that the protein is downregulated (Cas, abbreviated form os caspase).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: Significantly altered proteins involved in apoptosis found in EVs derived from RTP801‐overexpressing neurons compared to the control. Pro‐apoptotic proteins are shown in red, anti‐apoptotic proteins in green, and proteins with a dual role as pro‐ and anti‐apoptotic in orange. Up‐arrows indicate that the protein is upregulated and down‐arrows that the protein is downregulated (Cas, abbreviated form os caspase).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Derivative Assay, Control, Activation Assay, Blocking Assay, Activity Assay, Knockdown, Inhibition, Migration, In Vivo, Over Expression, Knock-Out, In Vitro

    Significantly altered proteins involved in apoptosis in EVs derived from neurons where  RTP801  was silenced with an shRNA compared to the control. Pro‐apoptotic proteins are shown in red, anti‐apoptotic proteins in green, and proteins with a dual role as pro‐ and anti‐apoptotic in orange. Up‐arrows indicate that the protein is upregulated and down‐arrows that the protein is downregulated (Cas, abbreviated form of caspase).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: Significantly altered proteins involved in apoptosis in EVs derived from neurons where RTP801 was silenced with an shRNA compared to the control. Pro‐apoptotic proteins are shown in red, anti‐apoptotic proteins in green, and proteins with a dual role as pro‐ and anti‐apoptotic in orange. Up‐arrows indicate that the protein is upregulated and down‐arrows that the protein is downregulated (Cas, abbreviated form of caspase).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Derivative Assay, shRNA, Control, Activation Assay, Knockdown, Inhibition, Histone Deacetylase Assay, Over Expression

    EVs derived from RTP801 overexpressing neurons induce neuron cell death via apoptosis. (a) Schematic representation of the experimental procedure. Cultured cortical neurons were transduced with lentiviral particles containing eGFP, eGFP‐RTP801, shCT and shRTP801 constructs. EVs were isolated from the culture medium and used to treat sister cortical neurons at three different doses: 400, 800 and 1,600 EVs:cell. After 24 h, neurons were fixed, and immunofluorescence against active caspase‐3 was performed. (b) Representative images of neuronal cultures at DIV14. MAP2 (in green) is used to identify neurons and ClvCas3 (in red) to identify cells expressing cleaved caspase‐3. Scale bar of 50 µm. (c) Neuronal nuclei were classified by phenotype: ClvCas3(+) (red outline) represents neurons expressing ClvCas3 and ClvCas3(‐) (blue outline) represents neurons with no active caspase‐3. Scale bar of 50 μm. Neuronal nuclei were then classified by machine learning into viable or apoptotic. Apoptotic nuclei were subclassified as condensed and fragmented. (d) Confusion matrix obtained with the classification training with CellProfiler Analyst. (e) ClvCas3 mean intensity in neurons. Data of the 3 doses of EVs‐treatment. (f) Data of ClvCas3 mean intensity only at the highest EVs dose (1,600 EVs:cell). (g) Quantification of neurons undergoing the last step of the apoptotic process (Fragmented ClvCas(‐) neuronal nuclei). At least neurons of 5 different fields were analysed per replicate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data was analysed by One‐way ANOVA (*P < 0.05, **P < 0.01, ****P < 0.0001).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: EVs derived from RTP801 overexpressing neurons induce neuron cell death via apoptosis. (a) Schematic representation of the experimental procedure. Cultured cortical neurons were transduced with lentiviral particles containing eGFP, eGFP‐RTP801, shCT and shRTP801 constructs. EVs were isolated from the culture medium and used to treat sister cortical neurons at three different doses: 400, 800 and 1,600 EVs:cell. After 24 h, neurons were fixed, and immunofluorescence against active caspase‐3 was performed. (b) Representative images of neuronal cultures at DIV14. MAP2 (in green) is used to identify neurons and ClvCas3 (in red) to identify cells expressing cleaved caspase‐3. Scale bar of 50 µm. (c) Neuronal nuclei were classified by phenotype: ClvCas3(+) (red outline) represents neurons expressing ClvCas3 and ClvCas3(‐) (blue outline) represents neurons with no active caspase‐3. Scale bar of 50 μm. Neuronal nuclei were then classified by machine learning into viable or apoptotic. Apoptotic nuclei were subclassified as condensed and fragmented. (d) Confusion matrix obtained with the classification training with CellProfiler Analyst. (e) ClvCas3 mean intensity in neurons. Data of the 3 doses of EVs‐treatment. (f) Data of ClvCas3 mean intensity only at the highest EVs dose (1,600 EVs:cell). (g) Quantification of neurons undergoing the last step of the apoptotic process (Fragmented ClvCas(‐) neuronal nuclei). At least neurons of 5 different fields were analysed per replicate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data was analysed by One‐way ANOVA (*P < 0.05, **P < 0.01, ****P < 0.0001).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Derivative Assay, Cell Culture, Transduction, Construct, Isolation, Immunofluorescence, Expressing

    Treatment with EVs derived from RTP801 overexpressing neurons reduces neuron arborization while EVs derived from shRTP801 increase neuron morphology's complexity. (a) Neurons were untreated (UT) or treated with EVs derived from eGFP, eGFP‐RTP801, shCT or shRTP801 transduced neurons, at a dose of 1,600 EVs:cell. Immunocytochemistry of MAP2 was performed to visualize cultured neurons. Using CellProfiler software, neurons not touching the borders of the image were identified as independent objects, and neuron skeleton was obtained. (b) Representative images of neuron arborization in UT neurons and neurons treated with EVs derived from eGFP, RTP801, shCT or shRTP801 transduced neurons. (c) Morphological assessment of neurons. Primary dendrites, intermediate branches, termini branches (endpoints), and the total tree length were analysed. Scale bar of 50 μm. At least neurons of 5 different fields were analysed per replicate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data was analysed by One‐way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: Treatment with EVs derived from RTP801 overexpressing neurons reduces neuron arborization while EVs derived from shRTP801 increase neuron morphology's complexity. (a) Neurons were untreated (UT) or treated with EVs derived from eGFP, eGFP‐RTP801, shCT or shRTP801 transduced neurons, at a dose of 1,600 EVs:cell. Immunocytochemistry of MAP2 was performed to visualize cultured neurons. Using CellProfiler software, neurons not touching the borders of the image were identified as independent objects, and neuron skeleton was obtained. (b) Representative images of neuron arborization in UT neurons and neurons treated with EVs derived from eGFP, RTP801, shCT or shRTP801 transduced neurons. (c) Morphological assessment of neurons. Primary dendrites, intermediate branches, termini branches (endpoints), and the total tree length were analysed. Scale bar of 50 μm. At least neurons of 5 different fields were analysed per replicate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data was analysed by One‐way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Derivative Assay, Immunocytochemistry, Cell Culture, Software

    6‐OHDA exposure increases RTP801 protein levels in EVs and elevates their secretion in cortical primary cultures. (a) Rat cortical neurons at DIV14 were treated with the toxin 6‐OHDA 50 µM for 16 h or untreated (UT) as control. Afterward, cell media was collected, and EVs were isolated by sequential centrifugations. EVs suspension was negatively stained and observed by TEM. Electron micrographs show the presence of vesicles between 30 and 110 nm. Scale bars are 500 nm and 200 nm in magnification micrographs (b) Sister cultures were treated with 6‐OHDA 50 μM for 16 h or not (∅) and total protein content was analysed by WB. Membranes were probed against RTP801 and NEDD4, TSG101, and Flotillin‐1 as EVs markers and actin as a loading control. Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Representative immunoblots are shown. Data were analysed by Student's T ‐test in the cell lysate and the EVs fraction (* P < 0.05, ** P < 0.01).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: 6‐OHDA exposure increases RTP801 protein levels in EVs and elevates their secretion in cortical primary cultures. (a) Rat cortical neurons at DIV14 were treated with the toxin 6‐OHDA 50 µM for 16 h or untreated (UT) as control. Afterward, cell media was collected, and EVs were isolated by sequential centrifugations. EVs suspension was negatively stained and observed by TEM. Electron micrographs show the presence of vesicles between 30 and 110 nm. Scale bars are 500 nm and 200 nm in magnification micrographs (b) Sister cultures were treated with 6‐OHDA 50 μM for 16 h or not (∅) and total protein content was analysed by WB. Membranes were probed against RTP801 and NEDD4, TSG101, and Flotillin‐1 as EVs markers and actin as a loading control. Graphs show values obtained by densitometric analysis of WB data relative to the total protein content of the cell lysate. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Representative immunoblots are shown. Data were analysed by Student's T ‐test in the cell lysate and the EVs fraction (* P < 0.05, ** P < 0.01).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Control, Isolation, Suspension, Staining, Western Blot

    6‐OHDA‐induced RTP801 counteract EVs trophic effect in recipient neurons. (a) Rat cortical neurons at DIV10 were untransduced (CT) or transduced with shCT or shRTP801. Seventy‐hours later, cells were exposed to 6‐OHDA 50 µM or not (∅) for 16 h. After that, EVs were isolated from the culture media by sequential centrifugations and EVs were administrated to cortical cultures (400 EVs:cell), and a control condition without EVs treatment was performed as a negative control (UT). Twenty‐four hours later, cells were harvested, and protein extracts were subjected to western blotting. (b) Membranes were probed against phosho‐Ser473‐Akt, Phospho‐Ser235/236‐RPS6, total Akt, total RPS6 and actin as a loading control. Representative immunoblots are shown. (c) Densitometric analysis of phospho‐Ser473‐Akt levels and phospho‐Ser235/246‐RPS6 levels. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by One‐way ANOVA followed by Bonferroni's posthoc test. (*** P < 0.005, ** P < 0.01 , *P < 0.05).

    Journal: Journal of Extracellular Vesicles

    Article Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

    doi: 10.1002/jev2.12378

    Figure Lengend Snippet: 6‐OHDA‐induced RTP801 counteract EVs trophic effect in recipient neurons. (a) Rat cortical neurons at DIV10 were untransduced (CT) or transduced with shCT or shRTP801. Seventy‐hours later, cells were exposed to 6‐OHDA 50 µM or not (∅) for 16 h. After that, EVs were isolated from the culture media by sequential centrifugations and EVs were administrated to cortical cultures (400 EVs:cell), and a control condition without EVs treatment was performed as a negative control (UT). Twenty‐four hours later, cells were harvested, and protein extracts were subjected to western blotting. (b) Membranes were probed against phosho‐Ser473‐Akt, Phospho‐Ser235/236‐RPS6, total Akt, total RPS6 and actin as a loading control. Representative immunoblots are shown. (c) Densitometric analysis of phospho‐Ser473‐Akt levels and phospho‐Ser235/246‐RPS6 levels. Values represent culture replicates of at least three independent neuronal cultures (mean ± SEM). Data were analysed by One‐way ANOVA followed by Bonferroni's posthoc test. (*** P < 0.005, ** P < 0.01 , *P < 0.05).

    Article Snippet: Although RTP801 antibody (Proteintech, #10638‐1‐AP) show several non‐specific bands, the specific 34 KDa band has been widely validated using shRNAs against RTP801 (Canal et al., ; Malagelada et al., , , ; Martín‐Flores et al., , ; Pérez‐Sisqués, Martín‐Flores et al., ; Pérez‐Sisqués, Sancho‐Balsells et al., ; Pérez‐Sisqués, Solana‐Balaguer et al., ) or with a RTP801 KO model (Pérez‐Sisqués, Martín‐Flores et al., ).

    Techniques: Transduction, Isolation, Control, Negative Control, Western Blot